Skip to main content

Table 2 Multivariate logistic regression of MHR for hyperuricemia

From: Impact of monocyte to high-density lipoprotein ratio on prevalent hyperuricemia: findings from a rural Chinese population

Variables

Odds Ratio (95%CI)

Model 1

P value

Model 2

P value

Model 3

P value

MHR (per SD change)

1.394 (1.299, 1.496)

< 0.001

1.375 (1.280, 1.478)

< 0.001

1.252 (1.157, 1.355)

< 0.001

Quartiles of MHR

 Quartile 1

Reference

 

Reference

 

Reference

 

 Quartile 2

1.272 (1.035, 1.564)

0.022

1.243 (1.009, 1.531)

0.041

1.194 (0.963, 1.480)

0.106

 Quartile 3

1.447 (1.183, 1.771)

< 0.001

1.392 (1.135, 1.708)

0.002

1.264 (1.019, 1.569)

0.033

 Quartile 4

2.418 (2.001, 2.920)

< 0.001

2.320 (1.913, 2.813)

< 0.001

1.829 (1.477, 2.264)

< 0.001

P for trend

 

< 0.001

 

< 0.001

 

< 0.001

  1. Model 1: no adjustment; Model 2: adjusted for age, sex, race, education level, family annual income, physical activity, current smoking, current drinking; Model 3: adjusted for all the factors in model 2 and BMI, eGFR, TC, HDL-C, SBP, FPG, lipid-lowering drug, history of CVD
  2. Abbreviations: MHR Monocyte to high-density lipoprotein ratio, OR odds ratio, CI confidence interval, SD standard deviation. Other abbreviations as in Table 1
  3. Quartile 1: MHR < 0.227; Quartile 2: 0.227 ≤ MHR < 0.339; Quartile 3: 0.339 ≤ MHR < 0.484; Quartile 4: MHR ≥0.484
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X